Results 141 to 150 of about 82,412 (330)
Preclinical Cushing's syndrome in adrenal incidentalomas [PDF]
Adrenal tumors are usually diagnosed by clinical symptoms of hormone excess. The increasing use of ultrasound and computed tomography results in the detection of a substantial number of incidentally discovered adrenal tumors.
Allolio, B. +5 more
core
3D printed, personalized sustained release cortisol for patients with adrenal insufficiency
Sejad Ayyoubi +10 more
openalex +2 more sources
Abstract Central serous chorioretinopathy (CSC) is a chorioretinal disease characterised by serous subretinal fluid (SRF) in the macula, resulting in sudden central vision loss. It predominantly affects working‐age adults, particularly men aged 30 to 60 years.
I. Made Ferdiko Hutamadella +10 more
wiley +1 more source
Adrenal Insufficiency as a Cause of Loss of Consciousness: A Case Study
Fahimeh Soheilipour +2 more
openalex +1 more source
Abstract As they become older, adolescents tend to prefer sleeping and rising later. Yet, it is still unclear if these sleep changes occur due to advancing age or because adolescents are more pubertally mature. This was investigated cross‐sectionally in a sample of 121 Brazilian 9‐to‐17‐year‐olds.
Yessica Alejandra Martínez‐Sánchez +3 more
wiley +1 more source
Circulatory collapse requiring mechanical circulatory support in a child with autoimmune adrenal insufficiency: a case report [PDF]
Yahia Hejazi +3 more
openalex +1 more source
Management of adrenal insufficiency during Ramadan fasting: a survey of physicians [PDF]
Salem Beshyah +2 more
openalex +1 more source
Novel approaches for drug development against chronic primary pain: A systematic review
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus +5 more
wiley +1 more source
Evaluation of preclinical antipsychotic models used to support first‐in‐human clinical trials
Abstract Schizophrenia is regarded as a complex and heterogeneous psychiatric disorder, characterised by diverse symptoms and comorbidities, which complicate both clinical management and drug development. Current pharmacological treatment, primarily based on dopamine D2 receptor antagonism or partial agonism, which has not markedly progressed since the
Thi Viet Ha Nguyen +2 more
wiley +1 more source

